Perspectives: Anticoagulation Management
- Professor of Medicine
- Chief of Medical Department 2
- Municipal Hospital Friedrichstadt
- Dresden, Germany
Ensuring adherence to therapy in secondary VTE prevention and treatment
I think what has to be put in place is a surveillance system that is comparable to lab monitoring. Lab monitoring is challenging, but it provides, of course, a constant context to the patient, and this kind of contact would have to be transferred from vitamin K antagonist to all the anticoagulants. That means patients’ visits on a semi-regular basis. That means a diary comparable to what we call the anticoagulation path.
So the patients need to have these "passports" with them, and has to be implemented to ensure that the patient has taken his or her drug, and that the information is there in case the patient needs to be treated but cannot provide the information himself. Then doctors have to get used to these assessments, to see their patients on a regular basis, and to ensure that these drugs are being taken as prescribed.
A current anticoagulation therapy should be designed to allow for a balanced hemostatic response in each individual
About the Coagulation Center
The Coagulation Center is an educational resource for healthcare professionals. Guided by a global editorial board of experts, the Coagulation Center offers a range of clinical perspectives on balancing the benefit and risk of anticoagulation in a rapidly changing landscape. Within the Coagulation Center you will find roundtable discussions on anticoagulation management, materials for patient management including patient case studies, tools to help evaluate bleeding risk and stroke risk, and downloadable resources for your practice.